Skip to content

Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome

Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01698021
Acronym
QUANTUM
Enrollment
500
Registered
2012-10-02
Start date
2013-06-30
Completion date
2013-11-30
Last updated
2013-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Myocardial Infarction, Unstable Angina

Keywords

Creatine Kinase, MB form, Troponin, Acute coronary syndrome, myocardial infarction, Unstable angina

Brief summary

The new assay of troponins T (highly sensitive troponins) detects concentrations much lower than before. Few data are currently available on their kinetics during acute coronary syndrome, especially in regard to the correlation with CK MB. The aim of the present study is to describe the kinetic of highly sensitive troponins in acute coronary syndrome, to correlate it with the concentration of CK MB, and possibly to evaluate their prognostic value with respect to infarct size .

Detailed description

Patients who meet the inclusion criteria will have a highly sensitive troponins and CKMB assays q 8hr for the first day, and q 12h for the next 2 days. If clinically not indicated, the blood sample can be cancelled at any time, as in the case of a patient with an initial suspicion of acute coronary syndrome in which the final diagnosis is something else. Only patients with a definitive myocardial infarction will be analyzed. Subgroup analyses includes ST-elevation MI, Non ST-elevation MI, revascularization vs no revascularization, procedural myocardial infarction. Another analysis conducted is the correlation between the values of troponin and infarct size by echocardiography (in patients who have an echocardiography 2-7 days post AND 2-6 months post myocardial infarction)

Interventions

None listed

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>= 18 years-old * Clinical suspicion of an acute coronary syndrome; (will be analyzed only patients with aposteriori definitive diagnosis of unstable angina or myocardial infarction)

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
Evaluation of troponins kinetic in acute coronary syndromes.72 hours

Countries

Canada

Contacts

Primary ContactPaul Farand, MD MSc
paul.farand@usherbrooke.ca(819) 346-1110
Backup ContactFrancis Bonenfant, resident
francis.bonenfant@usherbrooke.ca(819) 346-1110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026